These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36376455)

  • 1. Proline, hydroxyproline, and pyrrolidone carboxylic acid derivatives as highly efficient but reversible transdermal permeation enhancers.
    Kopečná M; Macháček M; Roh J; Vávrová K
    Sci Rep; 2022 Nov; 12(1):19495. PubMed ID: 36376455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid derivatives as transdermal permeation enhancers.
    Janůšová B; Skolová B; Tükörová K; Wojnarová L; Simůnek T; Mladěnka P; Filipský T; Ríha M; Roh J; Palát K; Hrabálek A; Vávrová K
    J Control Release; 2013 Jan; 165(2):91-100. PubMed ID: 23154194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dodecyl Amino Glucoside Enhances Transdermal and Topical Drug Delivery via Reversible Interaction with Skin Barrier Lipids.
    Kopečná M; Macháček M; Prchalová E; Štěpánek P; Drašar P; Kotora M; Vávrová K
    Pharm Res; 2017 Mar; 34(3):640-653. PubMed ID: 28070753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery.
    Kopečná M; Macháček M; Prchalová E; Štěpánek P; Drašar P; Kotora M; Vávrová K
    Pharm Res; 2017 Oct; 34(10):2097-2108. PubMed ID: 28664316
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Dvořáková K; Štěpánek P; Kroupová J; Zbytovská J
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeation enhancers in transdermal drug delivery: benefits and limitations.
    Kováčik A; Kopečná M; Vávrová K
    Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids.
    Yi QF; Yan J; Tang SY; Huang H; Kang LY
    Drug Dev Ind Pharm; 2016; 42(7):1086-93. PubMed ID: 26635061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified stratum corneum model membranes for studying the effects of permeation enhancers.
    Čuříková BA; Procházková K; Filková B; Diblíková P; Svoboda J; Kováčik A; Vávrová K; Zbytovská J
    Int J Pharm; 2017 Dec; 534(1-2):287-296. PubMed ID: 29061325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fate of 1,8-cineole as a Chemical Penetrant: A Review.
    Dao L; Dong Y; Song L; Sa C
    Curr Drug Deliv; 2024; 21(5):697-708. PubMed ID: 37165499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the skin permeation barrier: challenges and opportunities.
    Vitorino C; Sousa J; Pais A
    Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination.
    Novotný J; Kovaríková P; Novotný M; Janůsová B; Hrabálek A; Vávrová K
    Pharm Res; 2009 Apr; 26(4):811-21. PubMed ID: 19009336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action.
    Novotný M; Klimentová J; Janůšová B; Palát K; Hrabálek A; Vávrová K
    J Control Release; 2011 Mar; 150(2):164-70. PubMed ID: 21093505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainable and efficient skin absorption behaviour of transdermal drug: The effect of the release kinetics of permeation enhancer.
    Ruan J; Liu C; Song H; Zhong T; Quan P; Fang L
    Int J Pharm; 2022 Jan; 612():121377. PubMed ID: 34915145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers.
    Kopečná M; Macháček M; Nováčková A; Paraskevopoulos G; Roh J; Vávrová K
    Sci Rep; 2019 Oct; 9(1):14617. PubMed ID: 31601936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers.
    Yoneto K; Ghanem AH; Higuchi WI; Peck KD; Li SK
    J Pharm Sci; 1995 Mar; 84(3):312-7. PubMed ID: 7616370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review on Potential Chemical and Herbal Permeation Enhancers Used in Transdermal Drug Delivery Systems.
    Raghav RS; Verma S; Monika
    Recent Adv Drug Deliv Formul; 2024; 18(1):21-34. PubMed ID: 38258784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the
    Schafer N; Balwierz R; Biernat P; Ochędzan-Siodłak W; Lipok J
    Mol Pharm; 2023 Jul; 20(7):3278-3297. PubMed ID: 37279070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations.
    Xu P; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic transdermal permeation enhancers: structure-activity relationships.
    Vávrová K; Zbytovská J; Hrabálek A
    Curr Med Chem; 2005; 12(19):2273-91. PubMed ID: 16178785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.